10x Genomics股票（+7.5%）：临床消息推动股价突破52周新高 - Trefis
10x Genomics Stock (+7.5%): 52-Week High Breakout on Clinical News Flow - Trefis
生命科学资讯
生物技术与制药领域的最新动态
全球临床试验公司Catalyst Clinical加入全球CRO组合。
Worldwide Clinical Trials adds Catalyst Clinical to global CRO mixture
Nkarta首席执行官在摩根大通会议上全粉装扮，此举意义非凡。
Nkarta’s CEO wore head-to-toe pink at JPM. Here’s why it matters more than ever
10x Genomics合作推动平台向临床与AI诊断转型 - simplywall.st
10x Genomics Partnerships Shift Platform Toward Clinical And AI Diagnostics - simplywall.st
10X Genomics股价触及52周新高，达21.52美元——来自Investing.com加拿大站。
10X Genomics stock hits 52-week high of 21.52 USD By Investing.com - Investing.com Canada
赛默飞世尔科技与英伟达携手推进实验室AI自动化进程 - 实验室管理者
Thermo Fisher Scientific and NVIDIA Partner to Advance Laboratory AI Automation - Lab Manager
前Spero高管因抗生素疗效声明被美国证监会罚款
Former Spero execs fined by SEC over antibiotic efficacy claims
政府拨款法案包含药品福利管理改革与代金券重新授权内容。
Government funding bill features PBM reforms, voucher reauthorization
探究赛默飞世尔科技公司近期做空兴趣——Benzinga
Peering Into Thermo Fisher Scientific Inc's Recent Short Interest - Benzinga
欧盟议会通过《关键药品法案》下更严格的药品储备规定
EU Parliament adopts stricter drug stockpiling rules under Critical Medicines Act
分析师：安捷伦与丹纳赫或成凯杰潜在买家（纽约证券交易所代码：QGEN）- 来自Seeking Alpha
Agilent, Danaher could be potential buyers of Qiagen - analyst (QGEN:NYSE) - Seeking Alpha
Valneva撤回美国基孔肯雅热疫苗
Valneva withdraws chikungunya vaccine from US
2026年1月12日至16日医疗科技股涨跌榜
Med-tech gainers and losers for Jan. 12-16, 2026
沃特世公司安排2025年第四季度财报电话会议 - 雅虎财经新加坡
Waters Corporation Schedules Fourth Quarter 2025 Earnings Conference Call - Yahoo Finance Singapore
10X Genomics股价创52周新高，达21.52美元
10X Genomics stock hits 52-week high of 21.52 USD By Investing.com - Investing.com India
客户互动中心 - Illumina
Customer Engagement Center - Illumina
10x Genomics Inc (TXG) 1月20日交易上涨6.38% - GuruFocus
10x Genomics Inc (TXG) Trading 6.38% Higher on Jan 20 - GuruFocus
2026年1月20日监管动态
Regulatory actions for Jan. 20, 2026
2026年中国值得关注的六大药物
Six drugs to watch in China for 2026
12月重磅交易推动生物医药并购额创历史新高
December blockbusters push biopharma deal value to record high